EPS for OraSure Technologies, Inc. (OSUR) Expected At $0.10

October 14, 2018 - By Clifton Ray

Investors sentiment increased to 1.16 in Q2 2018. Its up 0.08, from 1.08 in 2018Q1. It is positive, as 19 investors sold OraSure Technologies, Inc. shares while 50 reduced holdings. 21 funds opened positions while 59 raised stakes. 53.44 million shares or 1.08% less from 54.02 million shares in 2018Q1 were reported.
Credit Suisse Ag reported 0% in OraSure Technologies, Inc. (NASDAQ:OSUR). First Quadrant L P Ca holds 0% or 9,021 shares. Credit Agricole S A holds 42,000 shares. Secor Limited Partnership invested in 0.05% or 35,937 shares. Guggenheim Capital Limited invested in 0% or 44,671 shares. Glenmede Trust Na holds 743 shares. Schwab Charles Invest has 0% invested in OraSure Technologies, Inc. (NASDAQ:OSUR). Prudential Finance Inc reported 0% stake. Robeco Institutional Asset Management Bv holds 0.02% or 223,288 shares. Deutsche Fincl Bank Ag owns 0.01% invested in OraSure Technologies, Inc. (NASDAQ:OSUR) for 549,057 shares. Cubist Systematic Strategies Limited has invested 0.02% in OraSure Technologies, Inc. (NASDAQ:OSUR). Numerixs Invest Techs invested in 0.02% or 4,900 shares. Signaturefd Limited Liability reported 845 shares stake. Moreover, California State Teachers Retirement has 0% invested in OraSure Technologies, Inc. (NASDAQ:OSUR). State Of Tennessee Treasury Department has invested 0% in OraSure Technologies, Inc. (NASDAQ:OSUR).

Since August 27, 2018, it had 0 insider buys, and 1 sale for $130,320 activity.

Analysts expect OraSure Technologies, Inc. (NASDAQ:OSUR) to report $0.10 EPS on November, 7.They anticipate $0.01 EPS change or 11.11 % from last quarter’s $0.09 EPS. OSUR’s profit would be $6.12M giving it 35.60 P/E if the $0.10 EPS is correct. After having $0.07 EPS previously, OraSure Technologies, Inc.’s analysts see 42.86 % EPS growth. The stock increased 0.21% or $0.03 during the last trading session, reaching $14.24. About 399,552 shares traded. OraSure Technologies, Inc. (NASDAQ:OSUR) has declined 26.69% since October 14, 2017 and is downtrending. It has underperformed by 42.31% the S&P500.

OraSure Technologies, Inc., together with its subsidiaries, develops, makes, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. The company has market cap of $871.11 million. It operates in two divisions, OSUR and DNAG. It has a 58.84 P/E ratio. The firm also offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests.

More news for OraSure Technologies, Inc. (NASDAQ:OSUR) were recently published by: Seekingalpha.com, which released: “Canaccord bullish on medical diagnostic firms” on September 14, 2018. Globenewswire.com‘s article titled: “OraSure Technologies Earnings Conference Call Invitation” and published on October 08, 2018 is yet another important article.

OraSure Technologies, Inc. (NASDAQ:OSUR) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Market News